Encompass Health (EHC) Stock Jumps As Q3 Earnings Confirm Margin Strength

Encompass Health stock rose 7.7% on Thursday to about US$131.49 after its Q3 2026 earnings were released. For a hospital operator that relies on steady inpatient rehabilitation volumes, that is a significant single-day move. The gain came as investors reviewed a quarter in which adjusted earnings per share and adjusted EBITDA both showed double digit growth, supported by higher acuity patients and expanding capacity.

The market reaction reflects today’s price jump, but the more important story lies in the multi-quarter pattern of stronger margins and upgraded full year guidance. That context now shapes how investors may evaluate the business over the next several years, rather than focusing solely on this trading session.

Like the look of Encompass Health’s double digit EPS and EBITDA gains but want a broader set of high quality operators with strong balance sheets and fundamentals? Check out the curated screener built around that profile in our list of solid balance sheet and fundamentals stocks (22 results)

Q3 2026 Earnings Summary

• Revenue (Q3 2026 vs. Q3 2025): US$1,609.5 million vs. US$1,477.5 million (up 8.9%)
• Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025): US$150.7 million vs. US$126.6 million (up 19.0%)
• Basic EPS (Q3 2026 vs. Q3 2025): US$1.53 vs. US$1.26 (up 23.6%)
• Adjusted EBITDA Margin Signal (Q3 2026 vs. Q3 2025): Adjusted EBITDA grew faster than sales, up 15.5% vs. 8.9% revenue growth (indicating margin expansion)

Prefer clean visuals instead of pages of earnings tables and accounting jargon? See Encompass Health’s full valuation picture laid out in clear, interactive charts in our company report for Encompass Health.

Encompass Health’s growth story meets hard execution tests

Supporters argue Encompass Health can turn demand and new capacity into efficient, profitable beds rather than empty buildings.

"Ongoing expansion of Encompass Health’s inpatient rehabilitation footprint through de novo hospitals, bed additions at high occupancy sites, and small format facilities, supported by a disclosed multi year pipeline and high returns on these projects, points to further discharge volume growth that can lift net operating revenue and EBITDA."

Q3 adds real proof points. Four hospitals and 189 beds opened year to date, plus 85 extra beds, with another 150 to 200 beds targeted in 2027. Management reports recent de novos reaching positive EBITDA by month 6 and about 70% occupancy by month 10, aligning economics with the narrative.

Testing Encompass Health’s expansion risks and payer friction

Skeptics worry that payer pushback and slower ramps could undercut that build out story and soften returns.

"The company is committing significant capital to new hospitals and bed additions based on past ramp profiles that target low to mid teens returns on de novos and very high returns on subsequent beds. If future sites take longer to reach occupancy or fail to achieve those economics, returns on invested capital and long term earnings could be lower than the current narrative assumes."

Recent openings are tracking historical ramp timelines, which argues against that concern for now. At the same time, Q3 bad debt at 2.7% of revenue and a trimmed Florida Medicaid benefit show reimbursement and collections friction can still chip away at the upside if replicated elsewhere.

One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all.

Hunt For Quiet Fundamental Shifts

Encompass Health just showed how a well executed operating story can move quickly from thesis to numbers. The real opportunity is hunting for stocks that could be undervalued before the market closes that gap.

• Company 1 - 44% below our estimate - moves from low margin assembly work into co-designing complex hardware central to customer product lifecycles.
• Company 2 - 26% below our estimate - embeds its chips and software at network choke points where critical data must be processed, transported, and secured.
• Company 3 - 43% below our estimate - converts a large backlog of data center and modular construction projects into higher value mechanical and electrical service work.

Three companies from the same screener. Open every one of the 30 undervalued companies on it →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com